VY6-19855-22823
3 vaccinations
5 coded responses
42 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 600 / IL
- Registered
- 2021-04-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Registered in v-safe
-
2021-04-20
Dose 1 — Moderna
-
2021-04-20
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Soreness around injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — days 1–6 daily, dose 1MedDRA: Pain, Pain in extremity — Feeling: Good · Site: Pain · Muscle or body achesFree text: Pain is soreness when moving injection arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
-
2021-05-19
Dose 2 — Moderna
- 2021-05-19
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
- 2021-06-02
- 2021-06-11
- 2021-06-16
- 2021-06-23
- 2021-06-30
-
2021-08-18
Survey response — 3 months, dose 2MedDRA: Anxiety, Fatigue, Panic attack — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Panic attacks, anxiety, fatigue.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-18
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-20
- 2021-11-17
-
2021-11-27
Dose 3 — Moderna
-
2021-11-27
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-11-29
-
2021-11-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-12-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-12-02
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-12-04
- 2021-12-11
-
2021-12-19
Survey response — day 21, dose 3MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, runny nose, cough.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-02-26
-
2022-05-28
Survey response — 6 months, dose 3MedDRA: Chest pain, Cough, Fatigue, Migraine, Pain, Paranasal sinus discomfort, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chest pains, upper right center and under left breast area. Coughing, sneezing, runny nose, sinus pressure migraines. Overall tiredness and soreness.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Moderna | |
| 2 | 2021-05-19 | Moderna | |
| 3 | 2021-11-27 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-18 | Unsuccessful |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Soreness around injection site.
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Pain is soreness when moving injection arm.
Release 9 — 3 months, dose 2
Symptoms: Panic attacks, anxiety, fatigue.
Release 10 — day 21, dose 3
Symptoms: Sore throat, runny nose, cough.
Release 11 — 6 months, dose 3
Symptoms: Chest pains, upper right center and under left breast area. Coughing, sneezing, runny nose, sinus pressure migraines. Overall tiredness and soreness.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Panic attack | ✓ | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release